Skip to content
Operation Infinite Justice – Lifestyle
Author:
Keenova Therapeutics
Keenova Announces Publication of XIAFLEX® (collagenase clostridium histolyticum) Manuscript in Translational Andrology and Urology
August 4, 2026
Keenova Therapeutics to Report Second Quarter 2026 Financial Results on August 11, 2026
July 30, 2026
Keenova Announces Publication of New Acthar® Gel (repository corticotropin injection) Manuscript in the Journal of Comparative Effectiveness Research
July 13, 2026
Keenova Announces Positive Phase 3 Results in Clinical Trial of XIAFLEX® (collagenase clostridium histolyticum) for Treating Plantar Fibromatosis
July 8, 2026
Keenova Champions Men’s Health Month with Education and Outreach
June 1, 2026